SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-22-002292
Filing Date
2022-02-03
Accepted
2022-02-03 08:15:22
Documents
14
Period of Report
2022-01-31
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K bcda20220202_8k.htm   iXBRL 8-K 29373
2 EXHIBIT 99.1 ex_331509.htm EX-99.1 19974
  Complete submission text file 0001437749-22-002292.txt   204734

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA noticker-20220131.xsd EX-101.SCH 4090
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE noticker-20220131_def.xml EX-101.DEF 13477
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE noticker-20220131_lab.xml EX-101.LAB 17675
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE noticker-20220131_pre.xml EX-101.PRE 13448
8 EXTRACTED XBRL INSTANCE DOCUMENT bcda20220202_8k_htm.xml XML 4349
Mailing Address 125 SHOREWAY ROAD SUITE B SAN CARLOS CA 94070
Business Address 125 SHOREWAY ROAD SUITE B SAN CARLOS CA 94070 650-226-0123
BioCardia, Inc. (Filer) CIK: 0000925741 (see all company filings)

IRS No.: 232753988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38999 | Film No.: 22586608
SIC: 2836 Biological Products, (No Diagnostic Substances)